Viewing Study NCT05301803



Ignite Creation Date: 2024-05-06 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 2:28 PM
Study NCT ID: NCT05301803
Status: COMPLETED
Last Update Posted: 2024-03-05
First Post: 2022-03-21

Brief Title: An Evaluation of the Safety and Performance of the CathVision ECGenius System
Sponsor: CathVision ApS
Organization: CathVision ApS

Study Overview

Official Title: A Prospective Single-Center Open-Label Single-Arm Study to Evaluate the Safety and Technical Performance of the CathVision ECGenius System
Status: COMPLETED
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective is to evaluate the safety and technical performance of the CathVision ECGenius System The secondary objective is to benchmark the intracardiac electrogram signal quality compared to commercially available systems in patients undergoing assessment and ablation of cardiac arrhythmias
Detailed Description: A prospective single center open-label single arm study to evaluate the safety and technical performance of the CathVision ECGenius system

Patients undergoing assessment and ablation of cardiac arrhythmias during an electrophysiology EP procedure and who meet all inclusion criteria will be enrolled in the study and undergo the EP procedure Intracardiac signals will be passively recorded using the CathVision ECGenius System in parallel with a commercial EP recording system and later compared and evaluated The investigational device will not be used for direct clinical care decisions or therapy The EP procedure will be guided by the study site Standards Of Care

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None